Mechanical thrombectomy of intracranial internal carotid occlusion - Pooled results of the MERCI and multi MERCI part I trials

被引:183
作者
Flint, Alexander C.
Duckwiler, Gary R.
Budzik, Ronald F.
Liebeskind, David S.
Smith, Wade S.
机构
[1] Univ Calif San Francisco, Neurovasc Serv & Neurocrit Care, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[3] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA USA
[5] Riverside Methodist Hosp, Dept Radiol, Columbus, OH USA
关键词
acute stroke; endovascular treatment; internal carotid artery; thrombectomy;
D O I
10.1161/01.STR.0000260187.33864.a7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Acute stroke from occlusion of the intracranial internal carotid artery (ICA) generally has a poor prognosis and appears to respond poorly to intravenous thrombolysis. Mechanical thrombectomy is a newly available modality for acute stroke therapy, but it is unknown whether this endovascular therapy may have a role in the specific setting of intracranial ICA occlusion. We therefore assessed the success rate of the Merci Retriever mechanical thrombectomy device in recanalization of intracranial ICA occlusions and sought to determine whether ICA recanalization with this therapy can result in better outcomes. Methods-All patients with acute stroke from intracranial ICA occlusion were identified in the MERCI and Multi MERCI Part I trials. We determined the success rate of ICA recanalization with endovascular thrombectomy and then assessed clinical outcomes according to whether vessel recanalization was successful. Results-Eighty patients with acute stroke from intracranial ICA occlusion were identified. Of these 80 patients, 53% had successful ICA recanalization with the Merci Retriever alone and 63% had ICA recanalization with use of the Merci Retriever plus adjunctive endovascular treatment. Baseline patient characteristics and procedural complications did not differ between the recanalized and nonrecanalized groups. Good clinical outcome, defined by a modified Rankin Scale of 0 to 2 at 90 days, occurred in 39% of patients with ICA recanalization (n = 19 of 49) and in 3% of patients without ICA recanalization (n = 1 of 30) (P < 0.001; one patient was lost to follow up for 90-day modified Rankin Scale). Ninety-day mortality was 30% (n = 15 of 50) in the recanalized group and 73% (n = 22 of 30) in the nonrecanalized group (P < 0.001). Symptomatic hemorrhage was not significantly different between the recanalized (6% [n = 3 of 50]) and nonrecanalized (16.7% [n = 5 of 30]) groups (P = 0.14). Hemorrhage rates were also not found to be influenced by use of intravenous thrombolysis before mechanical thrombectomy. Multivariable logistic regression identified ICA recanalization (OR = 28.4, 95% CI = 2.6 to > 99.9) and lack of history of hypertension (OR = 0.15, 95% CI = 0.04 to 0.57) as significant predictors of a good 90-day outcome. Failure to recanalize the ICA (OR = 0.16, 95% CI = 0.05 to 0.51) and age (per decade, OR = 1.07, 95% CI = 1.03 to 1.13) were significant predictors of mortality at 90 days. Conclusions-Mechanical thrombectomy of acute intracranial ICA occlusion using the Merci Retriever device, alone or in combination with adjunctive endovascular therapy, has a high rate of successful vessel recanalization. Subjects with successful ICA recanalization by this method have improved poststroke clinical outcome and survival compared with subjects in which the ICA is not successfully recanalized.
引用
收藏
页码:1274 / 1280
页数:7
相关论文
共 27 条
[1]   Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions [J].
Arnold, M ;
Nedeltchev, K ;
Mattle, HP ;
Loher, TJ ;
Stepper, F ;
Schroth, G ;
Brekenfeld, C ;
Sturzenegger, M ;
Remonda, L .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (06) :739-742
[3]   Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion [J].
Christou, I ;
Felberg, RA ;
Demchuk, AM ;
Burgin, WS ;
Malkoff, M ;
Grotta, JC ;
Alexandrov, AV .
JOURNAL OF NEUROIMAGING, 2002, 12 (02) :119-123
[4]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[5]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[6]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[7]   Does acute occlusion of the carotid T invariably have a poor outcome? [J].
Georgiadis, D ;
Oehler, J ;
Schwarz, S ;
Rousson, V ;
Hartmann, M ;
Schwab, S .
NEUROLOGY, 2004, 63 (01) :22-26
[8]   MERCI 1 - A phase 1 study of mechanical embolus removal in cerebral ischemia [J].
Gobin, YP ;
Starkman, S ;
Duckwiler, GR ;
Grobelny, T ;
Kidwell, CS ;
Jahan, R ;
Pile-Spellman, J ;
Segal, A ;
Vinuela, F ;
Saver, JL .
STROKE, 2004, 35 (12) :2848-2853
[9]   Local intra-arterial thrombolysis in acute ischemic stroke [J].
Gönner, F ;
Remonda, L ;
Mattle, H ;
Sturzenegger, M ;
Ozdoba, C ;
Lövblad, KO ;
Baumgartner, R ;
Bassetti, C ;
Schroth, G .
STROKE, 1998, 29 (09) :1894-1900
[10]  
Imai K, 2005, AM J NEURORADIOL, V26, P1395